(Q69728555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Individualizing gentamicin dosage in patients with cystic fibrosis: limitations to pharmacokinetic approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

1 reference

L Hendeles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

R P Iafrate

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

P C Stillwell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

J A Mangos

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

language of work or name

English

0 references

publication date

1 February 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

5 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

303-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections

5 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Tobramycin therapy of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis: effect of dosage and concentration of antibiotic in sputum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Pneumonia caused by coliforms and Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Pharmacokinetics of tobramycin in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Pharmacokinetics of tobramycin in patients with cystic fibrosis. Implications for the dosing interval.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Pharmacokinetics of Gentamicin in Children and Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

A model for dosing gentamicin in children and adolescents that adjusts for tissue accumulation with continuous dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Intravenous administration of medication in pediatric patients: problems and solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Gentamicin tissue accumulation and nephrotoxic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Gentamicin disposition and tissue accumulation on multiple dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

Individualization of tobramycin dosage in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980178-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(87)80178-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3806307%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference